Validation of an extended version of the SEIQoL-DW in a cohort of Hodgkin lymphoma' survivors.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/46196CEB.svg?ark=w1%2F20260515%2F46196CEB)](https://nobleid.org/work/w1/20260515/46196CEB)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors